Effectiveness of a low gonadotrophin-releasing hormone antagonist dose in preventing premature luteinizing hormone rise during controlled ovarian stimulation

By Tiboni Gian Mario   Palumbo Paola   Leonzio Emiliana   Gabriele Elisabetta   Verna Ilde   Giampietro Franca  

Gynecological Endocrinology, Vol. 27, Iss. 11, 2011-11 ,pp. : 885-889

Informa Healthcare

Access to resources Recommend Favorite

Reducing the dose of gonadotrophin-releasing hormone agonist on starting ovarian stimulation: effect on ovarian response and in-vitro fertilization outcome

By Elgendy M   Afnan M  

Human Reproduction, Vol. 13, Iss. 9, 1998-09 ,pp. : 2382-2385

Oxford University Press

Access to resources Recommend Favorite

Infertility. Dose-finding study for the use of long-acting gonadotrophin-releasing hormone analogues prior to ovarian stimulation for IVF

By Yim S.F.   Lok I.H.   Cheung L.P.   Briton-Jones C.M.   Chiu T.T.Y.  

Human Reproduction, Vol. 16, Iss. 3, 2001-03 ,pp. : 492-494

Oxford University Press

Access to resources Recommend Favorite

Infertility. Continuous administration of gonadotrophin-releasing hormone agonist during the luteal phase in IVF

By Fujii Shunsaku   Sato Shigemi   Fukui Atsushi   Kimura Hidetaka   Kasai Goichiro  

Human Reproduction, Vol. 16, Iss. 8, 2001-08 ,pp. : 1671-1675

Oxford University Press

Access to resources Recommend Favorite

Influence of gonadotrophin-releasing hormone agonist total dose in the ovarian stimulation in the long down-regulation protocol for in-vitro fertilization

By Alvarez C.   Cremades N.   Blasco N.   Bernabeu R.  

Human Reproduction, Vol. 12, Iss. 11, 1997-11 ,pp. : 2366-2369

Oxford University Press

Access to resources Recommend Favorite